Crossject Valuation

ALCJ Stock  EUR 2.18  0.21  10.66%   
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Crossject shows a prevailing Real Value of €1.99 per share. The current price of the firm is €2.18. Our model approximates the value of Crossject from analyzing the firm fundamentals such as Return On Equity of -10.14, current valuation of 117.24 M, and Profit Margin of (2.77) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Crossject's valuation include:
Price Book
40.5323
Enterprise Value
117.2 M
Enterprise Value Ebitda
(14.92)
Price Sales
25.1807
Enterprise Value Revenue
441.8507
Overvalued
Today
2.18
Please note that Crossject's price fluctuation is very risky at this time. Calculation of the real value of Crossject is based on 3 months time horizon. Increasing Crossject's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Crossject is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Crossject Stock. However, Crossject's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  2.18 Real  1.99 Hype  2.18 Naive  2.23
The real value of Crossject Stock, also known as its intrinsic value, is the underlying worth of Crossject Company, which is reflected in its stock price. It is based on Crossject's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Crossject's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
1.99
Real Value
5.48
Upside
Estimating the potential upside or downside of Crossject helps investors to forecast how Crossject stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Crossject more accurately as focusing exclusively on Crossject's fundamentals will not take into account other important factors:
Earnings
Estimates
LowProjectedHigh
-0.06-0.06-0.06
Details
Hype
Prediction
LowEstimatedHigh
0.112.185.67
Details
Naive
Forecast
LowNext ValueHigh
0.042.235.72
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Crossject's intrinsic value based on its ongoing forecasts of Crossject's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Crossject's closest peers. If more than one evaluation category is relevant for Crossject we suggest using both methods to arrive at a better estimate.

Crossject Cash

5.25 Million

Crossject Total Value Analysis

Crossject is presently forecasted to have takeover price of 117.24 M with market capitalization of 102.56 M, debt of 18.35 M, and cash on hands of 154 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Crossject fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
117.24 M
102.56 M
18.35 M
154 K

Crossject Investor Information

About 24.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.22. Crossject had not issued any dividends in recent years. The entity had 518:509 split on the 10th of June 2025. Based on the key indicators related to Crossject's liquidity, profitability, solvency, and operating efficiency, Crossject may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.

Crossject Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Crossject has an asset utilization ratio of 13.04 percent. This suggests that the Company is making €0.13 for each dollar of assets. An increasing asset utilization means that Crossject is more efficient with each dollar of assets it utilizes for everyday operations.
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Crossject Profitability Analysis

Based on Crossject's profitability indicators, Crossject may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Crossject's ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2009-12-31
Previous Quarter
-6.4 M
Current Value
-4.9 M
Quarterly Volatility
2.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
The current year's Gross Profit is expected to grow to about (18.7 M). In addition to that, Pretax Profit Margin is expected to decline to -4.58
For Crossject profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Crossject to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Crossject utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Crossject's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Crossject over time as well as its relative position and ranking within its peers.

Crossject Earnings per Share Projection vs Actual

By analyzing Crossject's earnings estimates, investors can diagnose different trends across Crossject's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Crossject is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Yuan Drop
 
Covid
 
Interest Hikes
Crossject is projected to generate -0.0575 in earnings per share on the 31st of December 2023. Crossject earnings estimates show analyst consensus about projected Crossject EPS (Earning Per Share). It derives the highest and the lowest estimates based on Crossject's historical volatility. Many public companies, such as Crossject, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Crossject Ownership Allocation

Crossject holds a total of 52.17 Million outstanding shares. Crossject retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Crossject Profitability Analysis

The company reported the revenue of 4.12 M. Net Loss for the year was (12.79 M) with loss before overhead, payroll, taxes, and interest of (8.65 M).
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Crossject's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Crossject and how it compares across the competition.

About Crossject Valuation

The stock valuation mechanism determines Crossject's current worth on a weekly basis. Our valuation model uses a comparative analysis of Crossject. We calculate exposure to Crossject's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Crossject's related companies.
Last ReportedProjected for Next Year
Gross Profit-19.7 M-18.7 M
Pretax Profit Margin(4.37)(4.58)
Operating Profit Margin(4.26)(4.47)
Net Loss(3.58)(3.75)
Gross Profit Margin(6.12)(6.42)

Complementary Tools for Crossject Stock analysis

When running Crossject's price analysis, check to measure Crossject's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crossject is operating at the current time. Most of Crossject's value examination focuses on studying past and present price action to predict the probability of Crossject's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crossject's price. Additionally, you may evaluate how the addition of Crossject to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Transaction History
View history of all your transactions and understand their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.